Debut Plus

₹48.63

▼ -0.66 -1.34%

As of 23 Oct 2026 · delayed

NSE Listed · Pharmaceuticals

Alpa Laboratories Ltd. (ALPA)

Volume: 14,176Avg Vol 1W: 13,360Avg Vol 1M: 20,85952W Range:₹46.1₹93.85
NSE BSE www.alpalabs.in AI Report
Key Ratios
Checked 7h ago
Market Cap₹104 Cr
Current Price₹48.63
Previous Close₹49.29
High / Low (52w)₹93.85 / ₹46.1
Volume14,176
Avg Vol (1W)13,360
Avg Vol (1M)20,859
Stock P/E25.54
Book Value₹88.53
Dividend Yield0%
ROE8.06%
ROA167.67%
Revenue (TTM)—
Revenue Growth3.41%
Profit Margin366.96%
Total Debt₹0 Cr
Shares Outstanding2 Cr
Face Value₹10
EPS (TTM)₹1.93
P/B0.56
Debt / Equity0.01
50 DMA₹59.95
200 DMA₹65.57
Day change-1.34%
Price Chart
₹48.63▼ 45.97% · 1Y
₹103₹463.4L
2025-10-27
2026-10-23

20-day avg volume: 19K shares

Pros
  • Company is almost debt-free.
  • Stock trades below its book value.
Cons
  • Revenue fell 24% YoY.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹25 Cr₹26 Cr₹40 Cr₹19 Cr₹26 Cr₹29 Cr₹31 Cr₹24 Cr
EBITDA₹10 Cr₹9 Cr₹2 Cr₹12 Cr₹0 Cr₹2 Cr₹3 Cr₹1 Cr
Net Profit₹8 Cr₹9 Cr₹-2 Cr₹12 Cr₹0 Cr₹2 Cr₹1 Cr₹1 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026Jun 2026
Revenue₹136 Cr₹39 Cr₹19 Cr₹26 Cr₹30 Cr₹31 Cr₹122 Cr₹24 Cr
EBITDA₹26 Cr₹2 Cr₹12 Cr₹0 Cr₹2 Cr₹3 Cr₹17 Cr₹1 Cr
Net Profit₹20 Cr₹-2 Cr₹12 Cr₹0 Cr₹2 Cr₹1 Cr₹15 Cr₹1 Cr
EPS9.34—————6.71—
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹121 Cr₹121 Cr₹140 Cr₹155 Cr₹167 Cr₹182 Cr₹223 Cr₹242 Cr
Total Liabilities₹23 Cr₹21 Cr₹33 Cr₹34 Cr₹33 Cr₹30 Cr₹51 Cr₹56 Cr
Equity₹98 Cr₹100 Cr₹108 Cr₹122 Cr₹135 Cr₹152 Cr₹171 Cr₹186 Cr
Total Debt————————
Cash Flow
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹1 Cr₹19 Cr₹1 Cr₹13 Cr₹12 Cr₹7 Cr₹22 Cr₹12 Cr
Investing₹-15 Cr₹-11 Cr₹6 Cr₹-16 Cr₹2 Cr₹-13 Cr₹-12 Cr₹-11 Cr
Financing₹-5 Cr₹-1 Cr₹0 Cr₹5 Cr₹-4 Cr₹3 Cr₹-5 Cr₹2 Cr
Free Cash Flow₹1 Cr₹19 Cr₹1 Cr₹13 Cr₹13 Cr₹7 Cr₹22 Cr₹12 Cr
Shareholding
Promoter 57.19% Institutions 0.42% Public 42.39%
Efficiency & Working Capital
ROCE9%
Interest Coverage65.2
Dividend Payout—
Debtor Days141 d
Inventory Days46 d
Payable Days61 d
Cash Conversion Cycle125 d
Working Capital Days187 d
Shareholding Details

As of 2026-09-30

Promoter57.2%
FII0.4%
DII0.1%
Institutions0.4%
Public42.4%
Promoter Pledge0%
No. of Shareholders17,347
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodDec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Sept 2026
Promoters57.3%57.3%57.3%57.3%57.3%57.3%57.3%57.3%57.3%57.2%57.2%57.2%
FIIs1%0.5%0.4%0.7%0.4%0.4%0.4%0.4%0.4%0.4%0.4%0.4%
DIIs0%0%0%0%0%0%0%0%0%0%0.1%0.1%
Public41.8%42.2%42.3%42%42.4%42.3%42.3%42.4%42.3%42.4%42.4%42.4%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders18,68218,69018,11618,88519,20618,87218,85118,54218,23617,90017,64317,347
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Paresh ChawlaShareholding of Promoter and Promoter Group34.3%72,08,210
Shitul ShahShareholding of Promoter and Promoter Group10.2%21,34,780
Bakulesh ShahShareholding of Promoter and Promoter Group4.9%10,26,600
Rima ShahShareholding of Promoter and Promoter Group3.7%7,75,200
Rupal ShahShareholding of Promoter and Promoter Group2.7%5,58,780
Soni ChawlaShareholding of Promoter and Promoter Group1.6%3,26,800
Pravin ShahShareholding of Promoter and Promoter Group0%1,000
Mahendra Singh ChawlaShareholding of Promoter and Promoter Group0%1,000
Asha ChawlaShareholding of Promoter and Promoter Group0%700
Bakulesh Shah HufShareholding of Promoter and Promoter Group0%0
Board of Directors
NameDesignationYear
Mahendra Singh ChawlaChairman & Exec. Director2025
Vitthal KothanaE D & Wholetime Director2025
Paresh ChawlaED / MD / Promoter2025
Pravin C ShahWTD & Executive Director2025
Shitul ShahWTD & Executive Director2025
Pratik ShahIndependent Non Exe. Director2025
Jyoti JainIndependent Non Exe. Director2025
BAHETI SANKETIndependent Non Exe. Director2025
Sunil ValechaIndependent Non Exe. Director2025
Pratibha LunawatIndependent Non Exe. Director2025
Segments — Product
SegmentRevenueShare
Drugs and chemicals₹0 Cr—
Segments — Geography
RegionRevenueShare
Outside India₹20 Cr31.1%
Within India₹45 Cr68.9%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹10252121
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-14Board Meetings—
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202614006425
202614000418
2026000607
Insider / Designated-Person Trades

2 recent disclosure(s)

VINIT SHAHAcquisition · 21,940
BAKULESH CHANDULAL SHAH HUFDisposal · 21,940
Substantial Acquisitions (SAST)

13 disclosure(s)

Off Market25/06/2025 · 11,00,580
-25/06/2025 · 11,00,580
Off Market25/06/2025 · 11,00,580
Off Market16/06/2025 · 1,09,000
-16/06/2025 · 1,09,000
Off Market16/06/2025 · 1,09,000
Company Information
Incorporated1988
ChairmanMahendra Singh Chawla
AuditorC H Padliya & Co
Investor Email[email protected]
🌐 www.alpalabs.in ↗

📍 33/2 Pigdamber, A B Road Rau, Indore, Madhya Pradesh, 453446

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Allcargo Logistics Ltd.Alldigi Tech LimitedAll E Technologies Ltd.All Time Plastics LimitedAlmondz Global Securities Ltd.Alok Industries LimitedAlpex Solar LimitedAAFS MARKET LINK2027SR IAlphageo (India) LimitedAlpine Texworld LimitedAlpine Texworld LimitedAlufluoride Ltd.All “A” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search